Page last updated: 2024-10-24

Golgi transport complex

Definition

Target type: cellularcomponent

A multisubunit tethering complex of the CATCHR family (complexes associated with tethering containing helical rods) that has a role in tethering vesicles to the Golgi prior to fusion. Composed of 8 subunits COG1-8. [GOC:krc, PMID:11980916, PMID:20972446, PMID:9792665]

The Golgi transport complex is a dynamic cellular structure responsible for the sorting, packaging, and delivery of proteins and lipids synthesized in the endoplasmic reticulum (ER). This complex is comprised of interconnected flattened sacs, known as cisternae, arranged in a stack, typically of 4 to 8 cisternae. Each cisterna possesses a distinct environment, allowing for the compartmentalization of specific functions during cargo processing.

**Golgi Transport Complex: A Multi-Component System**

1. **Cisternae:** The core of the Golgi complex, these flattened sacs provide the platform for various enzymatic reactions and protein modifications.

2. **Golgi Matrix:** A protein scaffold that provides structural support and facilitates the movement of cargo through the stack. It is composed of a network of fibers and proteins that interact with the cisternae and associated proteins.

3. **Golgi-Associated Proteins (GAPs):** A diverse set of proteins located in the Golgi complex, each with specific roles in protein sorting, modification, and transport. Some key GAPs include:

* **Coat Proteins (COPI and COPII):** Involved in the budding and trafficking of vesicles from the ER to the Golgi and between Golgi cisternae.
* **SNARE proteins:** Regulate vesicle fusion, ensuring that cargo is delivered to the appropriate target compartments.
* **Golgi enzymes:** Catalyze a variety of modifications, including glycosylation, phosphorylation, and sulfation, which are crucial for protein function and targeting.

4. **Vesicles:** Small, membrane-bound sacs that bud from the Golgi cisternae and transport cargo to other organelles, including lysosomes, the plasma membrane, and other secretory pathways.

**Functional Organization of the Golgi Transport Complex**

The Golgi is structured as a series of distinct compartments:

* **Cis Golgi Network (CGN):** The entry point for proteins and lipids from the ER, where they are sorted and begin their journey through the Golgi.
* **Medial Golgi:** The central region of the Golgi, characterized by the presence of specific enzymes involved in further protein modifications.
* **Trans Golgi Network (TGN):** The exit point for cargo, where proteins are sorted into different transport vesicles based on their destination.

**Dynamic Nature of the Golgi**

The Golgi is not a static structure. It is constantly changing, with new cisternae forming and older ones being recycled or degraded. The process of cargo movement through the Golgi is also dynamic, with vesicles continuously budding and fusing with the cisternae, ensuring the efficient and regulated delivery of proteins and lipids to their final destinations.

**Key Functions of the Golgi Transport Complex**

* **Protein sorting:** Separating proteins destined for different locations within the cell.
* **Protein modification:** Adding or removing sugars, phosphates, or other modifications to proteins.
* **Packaging and delivery:** Assembling proteins into functional complexes and packaging them into vesicles for transport.
* **Lipid metabolism:** Synthesizing and modifying lipids, including those involved in membrane formation.

**Importance of the Golgi Transport Complex**

The Golgi transport complex is essential for cell function, playing a crucial role in the biosynthesis and distribution of cellular components. Disruptions in Golgi function can lead to a range of cellular dysfunctions and diseases, including cancer, neurodegenerative disorders, and metabolic diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Cell division control protein 42 homologA cell division control protein 42 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P60953]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
fasudilfasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

fasudil: intracellular calcium antagonist; structure in first source
isoquinolines;
N-sulfonyldiazepane
antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
ketorolac5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.

ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.

Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
amino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate
analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
sanguinarine chloride
chelerythrine chloride
2-[[benzamido(sulfanylidene)methyl]amino]-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic acidCID1067700: a pan-GTPase inhibitor; structure in first sourcethienopyran
y 27632, dihydrochloride, (4(r)-trans)-isomer
secramine asecramine A: inhibits VSVG transport from the Golgi to the plasma membrane; also inhibits Cdc42-dependent cell functions; structure in first source